CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric) (CLINDAMYCIN PALMITATE HYDROCHLORIDE)
CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric) (CLINDAMYCIN PALMITATE HYDROCHLORIDE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric); Generic name: CLINDAMYCIN PALMITATE HYDROCHLORIDE; Manufacturer: Rising Pharma Holdings, Inc..
| Brand name | CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric) |
|---|---|
| Generic name | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
| Manufacturer | Rising Pharma Holdings, Inc. |
| Used for | INDICATIONS AND USAGE Clindamycin palmitate hydrochloride for oral solution, USP (Pediatric) (clindamycin palmitate HCl) is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of colitis, as described in the BOXED WARNING , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic |
| Dosage | DOSAGE AND ADMINISTRATION If significant diarrhea occurs during therapy, this antibiotic should be discontinued (see BOXED WARNING ). Concomitant administration of food does not adversely affect the absorption of clindamycin palmitate HCl contained in clindamycin palmitate hydrochloride for oral solution (Pediatric) flavored granules. Serious infections: 8-12 mg/kg/day (4-6 mg/lb/day) divided into 3 or 4 equal doses. Severe infections: 13-16 mg/kg/day (6.5-8 mg/lb/day) divided into 3 or 4 equal |
| Warnings | WARNINGS See BOXED WARNING. Clostridium difficile Associated Diarrhea Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including cindamycin palmitate hydrochloride for oral solution (Pediatric), and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C.difficile . C.difficile produces toxins A and B which contribute to the develop |
| Active ingredient(s) | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0800afad-e4cd-4f70-aaa1-a14547be4729 |